Conference paper

Teriparatide - new value in osteoporosis treatment: treatment guidelines

Mirko Koršić ; Department for Endocrinology and Metabolic Diseases, Clinic for Internal Medicine, Clinical Hospital Centre Zagreb, Zagreb, Croatia
Darko Kaštelan ; Department for Endocrinology and Metabolic Diseases, Clinic for Internal Medicine, Clinical Hospital Centre Zagreb, Zagreb, Croatia

Abstract

Osteoporosis has become global health issue due to the longer life-cycle and increased percentage of older people in population. The great improvement was done in the treatment of postmenopausal osteoporosis. By the mechanism of action, drugs for osteoporosis treatment are antiresorptives and osteoanabolics. Teriparatide is an osteoanabolic drug that stimulates bone turnover and building of a new bone, indicated for treatment of women in postmenopause with multiple osteoporotic fractures.

Keywords

osteoporosis; antiresorptives; osteoanabolics; teriparatid

Hrčak ID:

125835

URI

https://hrcak.srce.hr/125835

Publication date:

20.10.2006.

Article data in other languages: croatian

Visits: 2.420 *